Last spring RBJ put out a call for entrants to compete in its inaugural Imaging Innovation Awards. We opened the contest to all private radiology practices and hospital radiology departments that had recently completed a project combining creative thinking with coordinated teamwork to develop a notably original breakthrough in some particular aspect of medical imaging.

Gadolinium-based contrast agents are back in the news. Radiologists are fretting anew. But is gadolinium poisoning a fresh crisis in the making—or another overblown chapter in an ongoing saga?

Big data is changing everything having to do with business analytics, but report turnaround times remain at or near the top of radiology’s most scrutinized performance metrics. Here are seven simple strategies to supercharge efficiency.

As radiologists, are we working hard to improve our accuracy and service each day to help our patients and referring colleagues—or just coasting on autopilot until our next vacation or retirement?

The powerful independent congressional agency known as MedPAC, the Medicare Payment Advisory Commission, has recommended that MIPS be scrapped. Should the influential group get its way?

There’s no question that gadolinium-based contrast agents leave behind traces of the rare-earth metal in the human brain. These remnants can hang around for months or even years, and that goes for both the linear and macrocyclic varieties. What’s not settled is whether or not “gad” depositions cause harm.

Annual mammography screening beginning at age 30 may provide value to patients with dense breast tissue, a personal history of breast cancer or a family history of breast cancer, according to new research presented at RSNA 2018 in Chicago.

Valerie P. Jackson, MD, has been named the new president of the RSNA Board of Directors.